(Q30414998)

English

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

influenza vaccine

0 references

Herwig Kollaritsch

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Markus Alexander Zeitlinger

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Otfried Kistner

9

object named as

Otfried Kistner

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

8

object named as

Thomas R Kreil

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

11

object named as

Sandor Fritsch

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Hartmut J Ehrlich

1

object named as

Hartmut J Ehrlich

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

15

object named as

P Noel Barrett

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Markus Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Fritz Pinl

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Bernhard Schmitt

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Alexandra Loew-Baselli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Daniel Portsmouth

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Friedrich Maritsch

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Gerald Aichinger

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Borislava G Pavlova

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

0 references

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

4543-4551

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

A novel influenza A (H1N1) vaccine in various age groups.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria) in adult and elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

The 2009 A (H1N1) influenza virus pandemic: A review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Portrait of a year-old pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Seroprevalence to influenza A(H1N1) 2009 virus--where are we?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Probable Inference, the Law of Succession, and Statistical Inference

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Cross-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Comparison of influenza serological techniques by international collaborative study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.061

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.03.061

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22475864%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30414998&oldid=1564023323"